In September 2024, after patient enrollment was complete, the company announced the trial failed to meet its primary cognitive efficacy endpoints
Role of antioxidants and natural products in inflammation
Using sterile equipment, disinfecting vial stoppers with alcohol before each puncture, minimizing unnecessary vial access, and refrigerating the peptide promptly after use all help support good laboratory handling practices
Bring a prescription or pharmacy label to avoid questions at security checkpoints
Long-term habits still matter
GLP-1R agonism produces: Glucose-dependent insulin secretion (insulin released only when glucose is elevated) Suppression of glucagon secretion Delayed gastric emptying (contributing to satiety) Reduced appetite via central nervous system signalling in hypothalamic nuclei Potential cardiovascular protection (observed in clinical trials of GLP-1 agonist drugs) This receptor is the foundation of the entire GLP drug class, from exenatide to semaglutide